|
- Gablofen | Intrathecal Baclofen | For Healthcare Providers
Gablofen ® (baclofen injection) is a gamma-aminobutyric acid (GABA) ergic agonist indicated for use in the management of severe spasticity of cerebral or spinal origin in adult and pediatric patients age 4 years and above
- Severe Spasticity Treatment | Gablofen Intrathecal Baclofen
Gablofen, FDA-approved intrathecal baclofen, provides continued symptom relief thanks to targeted drug delivery via a pump Gablofen eases spasticity (the technical term for muscle and joint stiffness and pain), providing you with increased mobility and the ability to perform daily basic life tasks
- Reimbursement Codes and Details - Gablofen
Gablofen ® (baclofen injection) is a gamma-aminobutyric acid (GABA) ergic agonist indicated for use in the management of severe spasticity of cerebral or spinal origin in adult and pediatric patients age 4 years and above
- Concentration Calculator - Gablofen
Gablofen ® (baclofen injection) is a gamma-aminobutyric acid (GABA) ergic agonist indicated for use in the management of severe spasticity of cerebral or spinal origin in adult and pediatric patients age 4 years and above
- Why Patients Should Choose Us | Gablofen Intrathecal Baclofen
Discover the benefits of using Gablofen, an FDA-approved intrathecal baclofen to manage your muscle and joint pain
- Frequently Asked Questions from Healthcare Providers | Gablofen
Gablofen ® (baclofen injection) is a gamma-aminobutyric acid (GABA) ergic agonist indicated for use in the management of severe spasticity of cerebral or spinal origin in adult and pediatric patients age 4 years and above
- Prescribing Information for Providers | Gablofen
Gablofen ® (baclofen injection) is a gamma-aminobutyric acid (GABA) ergic agonist indicated for use in the management of severe spasticity of cerebral or spinal origin in adult and pediatric patients age 4 years and above
- Coding and Reimbursement for Intrathecal Therapy - gablofen. com
Gablofen® (baclofen injection) is a gamma-aminobutyric acid (GABA) ergic agonist indicated for use in the management of severe spasticity of cerebral or spinal origin in adult and pediatric patients age 4 years and above
|
|
|